Utility of MRI and PET/CT to differentiate benign versus malignant peripheral nerve sheath tumors (MPNST).

被引：0
|
作者：
Sebro, Ronnie [1 ]
Niziolek, Paul [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B17
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] Peripheral Nerve Sheath Tumors. Benign or Malignant? The Role of MRI and Ultrasonography in A Case Report
    Chatzistefanou, Alexandros
    Mantatzis, Michalis
    Deftereos, Savas
    Mintzopoulou, Paraskevi
    Prassopoulos, Panos
    JOURNAL OF NEUROIMAGING, 2014, 24 (03) : 308 - 310
  • [22] MR and 18F FDG PET/CT appearances of schwanomas and malignant peripheral nerve sheath tumour (MPNST)
    Haroon, Athar
    Sajjan, Rakesh
    Saad, Zia
    Syed, Rizwan
    Allie, Rayjanah
    Al-Nabhani, Khalsa
    Ben-Haim, Simona
    Gacinovic, Svetislav
    Bomanji, Jamshed
    Groves, Ashley
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] PARAVERTEBRAL MALIGNANT PERIPHERAL NERVE SHEATH TUMOUR (MPNST) IN A HORSE
    Nikolaou, G.
    de Bont, M.
    Herden, C.
    Hetzel, U.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2012, 146 (01) : 84 - 84
  • [24] Intrasellar malignant peripheral nerve sheath tumor (MPNST) - Comment
    Laws, Edward R.
    ACTA NEUROCHIRURGICA, 2007, 149 (02) : 206 - 206
  • [25] Paravertebral malignant peripheral nerve sheath tumour (MPNST) in a horse
    Nikolaou, G.
    de Bont, M. P.
    Herden, C.
    Hetzel, U.
    EQUINE VETERINARY EDUCATION, 2015, 27 (07) : e25 - e29
  • [26] The Molecular Landscape of Malignant Peripheral Nerve Sheath Tumour (MPNST)
    Lindsay, D.
    Hookway, E.
    Steele, C.
    Lombard, P.
    Gupta, M.
    Amary, F.
    Tirabosco, R.
    Ye, H.
    Strobl, A.
    Pillay, N.
    Flanagan, A. M.
    JOURNAL OF PATHOLOGY, 2019, 248 : S5 - S5
  • [27] Correlation Between FNCLCC Grading and Clinical Outcomes in Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Wakeman, Kristina
    Ricciotti, Robert
    Mantilla, Jose
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 86 - 87
  • [28] Phase II study of erlotinib in metastatic or unresectable malignant peripheral nerve sheath tumors (MPNST).
    Albritton, K. H.
    Rankin, C.
    Coffin, C. M.
    Ratner, N.
    Budd, G. T.
    Schuetze, S. M.
    Randall, R. L.
    Declue, J. E.
    Borden, E. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 524S - 524S
  • [29] Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors
    Feber, Andrew
    Wilson, Gareth A.
    Zhang, Lu
    Presneau, Nadege
    Idowu, Bernadine
    Down, Thomas A.
    Rakyan, Vardhman K.
    Noon, Luke A.
    Lloyd, Alison C.
    Stupka, Elia
    Schiza, Vassia
    Teschendorff, Andrew E.
    Schroth, Gary P.
    Flanagan, Adrienne
    Beck, Stephan
    GENOME RESEARCH, 2011, 21 (04) : 515 - 524
  • [30] Systemic therapy in NF-1 associated malignant peripheral nerve sheath tumors (MPNST)
    Munnangi, Pujita
    King, Bridgette L.
    Chiang, Y. Sabrina
    Conley, Anthony Paul
    Araujo, Dejka M.
    Livingston, J. Andrew
    Ludwig, Joseph Aloysius
    Nakazawa, Michael
    Haddad, Elise F. Nassif
    Ravi, Vinod
    Ratan, Ravin
    Zarzour, Maria Alejandra
    Patel, Shreyaskumar
    Torres, Keila E.
    Somaiah, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345